Evaluation of exposure of regorafenib and its metabolites in cancer patients with renal impairment by modelling, simulation, and clinical study

Authors :: Adriaan Cleton
F-T. Hafner
K. Schnizler
Funan Huang
Bart Ploeger
M. Block
Joachim Grevel
Zuzana Jirakova Trnkova
M. Gerisch
Susanne Reschke
I. Sturm
Source :: Annals of Oncology. 27:vi538
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Cancer
Hematology
medicine.disease
Clinical study
chemistry.chemical_compound
chemistry
Internal medicine
Regorafenib
medicine
Intensive care medicine
business

Tools